Dr. Elizabeth Algar has had nearly 20 years experience working on the genetics of paediatric cancer and cancer prediposition syndromes. She has published 38 articles in the peer-reviewed international literature. Dr. Algar is the head of a NATA accredited molecular genetics diagnostic and research group located within the Children's Cancer Centre at the Royal Children's Hospital and is funded by the Children's Cancer Centre Foundation. She is a regular reviewer for international scientific journals including Clincal Cancer Research, Cancer Research and Haematologica.
My key research interest is in understanding the genetic and epigenetic basis for cancer in childhood. Cancers that arise at a very early age, present ideal opportunities for the identification of key genes and pathways important in cell transformation, as they arise from cells that have not yet been exposed to a life-long accumulation of genetic and epigenetic damage. I am one of few researchers within Australia working in this area.Audio visual presentation - Application of methylation sensitve high resolution melting in the diagnosis of growth disorders. At www.rcpa.edu.au under members log-in